BVS Bioventus Earnings and EPS analysis

EPS in 2026 (TTM): $0.81

Last Report Period Date: Jun 27, 2026

As of September this year, based on Bioventus's most recent financial report, the company's trailing twelve months EPS is $0.81. During 2025, BVS reported a per-share earnings of $0.34, which shows a rise compared to the EPS of -$0.56 recorded in 2024. Bioventus's EPS for the quarterly period ending on Jun 27, 2026 came in at $0.49.

The yearly earnings per share during 2025 was $0.34, a rise of 160.7% compared to -$0.56 recorded in 2024. Over the quarter ending Jun 27, 2026, the earnings per share came in at $0.49, reflecting a 345.5% increase compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $0.81. During 2024, the annual earnings per share was -$0.56, representing an increase of 77.5% compared to 2023.

Bioventus has recorded a growth in earnings per share of 345.5% in the past 12 months (YoY, quarterly). Bioventus had an average annual EPS growth of -17.5% in the last five years.